Related Experiment Videos
Uremic cardiomyopathy: potential role of vitamin D and parathyroid hormone
Insights
Reducing parathyroid hormone (PTH) levels through vitamin D or parathyroidectomy improves left ventricular function in patients undergoing hemodialysis. Lowering PTH benefits the uremic heart, enhancing cardiac performance.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Chronic kidney disease patients on hemodialysis often experience secondary hyperparathyroidism.
- Elevated parathyroid hormone (PTH) and altered vitamin D metabolism can negatively impact cardiovascular health.
Purpose of the Study:
- To investigate the effects of parathyroid hormone (PTH) and vitamin D on left ventricular function in patients undergoing chronic hemodialysis.
- To determine if reducing PTH levels improves cardiac function in uremic patients.
Main Methods:
- M-mode echocardiography and systolic time intervals were used to assess left ventricular function.
- Interventions included vitamin D supplementation, magnesium level adjustment, and parathyroidectomy.
Main Results:
- Vitamin D treatment decreased PTH and improved fractional shortening (FS) and velocity of circumferential fiber shortening (Vcf).
- Increased plasma magnesium reduced PTH and showed a trend towards improved FS and Vcf.
- Parathyroidectomy in severe hyperparathyroidism led to significant increases in FS and Vcf.
Conclusions:
- Parathyroid hormone (PTH) and vitamin D significantly influence left ventricular function in uremic patients.
- Reducing plasma PTH levels is beneficial for the cardiac health of patients on chronic hemodialysis.
Abstract:
44 patients receiving regular hemodialysis therapy were investigated using M-mode echocardiography and systolic time intervals to examine the effects of parathyroid hormone (PTH) and vitamin D on left ventricular function. 12 patients were treated with 1 microgram daily of 1, alpha-hydroxycholecalciferol for 6 weeks, which produced a decrease in plasma PTH concentration from 1,883 +/- 226 to 1,123 +/- 289 ng/l. Fractional fibre shortening (FS) increased from 34.6 to 37.6% (p less than 0.025) and mean velocity of fibre shortening (Vcf) increased from 1.21 to 1.32 circ/s (p less than 0.01). A second group of 20 patients was studied before and after the plasma magnesium concentration was increased from 1.25 to 1.70 mmol/l, resulting in a fall in plasma PTH concentration from 546 to 418 ng/l (p less than 0.001). This was associated with an increase in both FS from 32.4 to 34.3%, and Vcf from 1.19 to 1.21 circ/s. A third group of 6 patients with severe hyperparathyroidism underwent total parathyroidectomy, FS increased from 34.9 to 36.3% and Vcf increased from 1.22 to 1.38 circ/s. In conclusion, our results indicate that vitamin D and PTH do influence left ventricular function in uremic patients on chronic hemodialysis, and that a reduction in plasma PTH levels is beneficial to the uremic heart.